Chordia Therapeutics
190A.TPharmaceutical
Filed as Chordia Therapeutics Inc. (2024-07–2026-04)
Financials · Standalone
| Fiscal year ended | 2025-08 | 2024-08 | 2023-08 | 2022-08 | 2021-08 | 2020-08 |
|---|---|---|---|---|---|---|
| Operating income | −¥1.8bn | −¥1.8bn | ¥212m | — | — | — |
| Ordinary income | −¥1.8bn | −¥1.8bn | ¥226m | −¥1.8bn | −¥525m | −¥975m |
| Total assets | ¥2.7bn | ¥4.6bn | ¥4.9bn | ¥4.5bn | ¥2.3bn | ¥1.2bn |
| Net assets / equity | ¥2.4bn | ¥4.2bn | ¥4.5bn | ¥4.3bn | ¥2.1bn | ¥1.0bn |
| Operating cash flow | −¥1.8bn | −¥1.9bn | ¥544m | −¥1.7bn | — | — |
| EPS (basic) | ¥-26.03 | ¥-31.11 | ¥3.96 | ¥-39.78 | ¥-3,016.58 | ¥-6,884.75 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 5
| Period | Form | Figures |
|---|---|---|
| 2025-09-01 → 2026-02-28 | Half-year | 61 figures · EDINET |
| 2024-09-01 → 2025-08-31 | Annual | 96 figures · EDINET |
| 2024-09-01 → 2025-02-28 | Half-year | 59 figures · EDINET |
| 2023-09-01 → 2024-08-31 | Annual | 91 figures · EDINET |
| 2023-09-01 → 2024-05-31 | Quarterly Q3 | 27 figures · EDINET |